MedTrace Logo

22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA

NCT03903471 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2022-09-29

No results posted yet for this study

Summary

The aim of this study is to compare the performance of 22G-ProCore and 22G-Standard needle in diagnosis of mediastinal and hilar lymphadenopathy via EBUS-TBNA with the purpose to explore the optimal technique for obtaining diagnostic material.

Conditions

  • Lymph Node Disease

Interventions

DEVICE

22G-ProCore Endobronchial Ultrasound Needle

EchoTip Procore® Endobronchial HD Ultrasound Biopsy Needle, COOK

DEVICE

22G-Standard Endobronchial Ultrasound Needle

EchoTip® Ultra Endobronchial High Definition Ultrasound Needle, COOK

Sponsors & Collaborators

  • Jiayuan Sun

    lead OTHER

Principal Investigators

  • Jiayuan Sun, MD,PhD · Shanghai Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-08
Primary Completion
2023-10-08
Completion
2023-10-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03903471 on ClinicalTrials.gov